Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ABEC Receives Certification from China | Contract Pharma
Breaking News

ABEC Receives Certification from China

As a qualified manufacturer of pressure vessels and components for use in China

ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, announced that its manufacturing facility in Kells, Co. Meath, Ireland has received certification from the People’s Republic of China as a qualified manufacturer of pressure vessels and components for use in China. 

ABEC Kells is the second of ABEC’s facilities to obtain its China Manufacture License (CML). ABEC’s Springfield, MO USA facility has held its CML since 2010. ABEC was awarded the CML for its Kells facility after a rigorous audit of its vessel engineering, manufacturing and quality processes by the China Special Equipment Inspection & Research Institute (CSEI).

The CML for Kells allows ABEC to provide fully-compliant systems from both the US and Europe, ensuring consistent and flexible supply to customers in China, as well as supporting foreign companies who are establishing manufacturing facilities in China.

“By earning the CML for Kells, ABEC continues to demonstrate our long-term commitment to customers in China,” said Scott Pickering, ABEC president and chief executive officer. “We are proud of this achievement and our industry leadership in global code compliance for equipment manufacturing.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters